Searchable abstracts of presentations at key conferences in endocrinology

ea0039ep51 | Diabetes | BSPED2015

High ferritin and glucose metabolism in diabetes – a case report.

Kumar Kiran , Yeo Mildrid

Iron is a transition metal that acts as an oxidant. There is evidence that systemic iron overload could contribute to abnormal glucose metabolism. Further research has showed that iron overload can result in an increased in type 2 diabetes irrespective of the cause of gene involved. Although the exact mechanism of iron-induced diabetes is uncertain, it is likely mediated by these three mechanisms: i) insulin deficiency, ii) insulin resistance, and iii) hepatic dysfunction....

ea0058p012 | Bone | BSPED2018

An unusual case of an infant presenting with Tetany and seizures secondary to phosphate supplementation

Gopalakrishna Nagapratheek , Kumar Kiran

Introduction: Hypocalcemia is a well known adverse reaction of phosphate supplements but rarely reported. We report a case of Infant presenting with hypocalcemic seizures after initiation of phosphate supplements.Clinical case: A baby Girl was born at 34+4 weeks gestation. She was admitted in NNU for preterm care. The admission was complicated by severe Gastroesophageal reflux disease(confirmed by PH impedance study), anemia and sepsis. She was discharge...

ea0039ep43 | Diabetes | BSPED2015

The effects of CSII on glycaemic control, hypoglycaemia, DKA and BMI in paediatric T1D patients.

Aldiss Peter , Santhanam Priyha , Kumar Kiran , Wolverson Marianne , Randell Tabitha , Denvir Louise , Sachdev Pooja

Background: Current NICE guidance states that insulin pump therapy (CSII) can be considered in Type 1 diabetes (T1DM) patients who suffer disabling hypoglycaemia in an attempt to reach glycaemic control or whose HbA1C remains high (>69 mmol/l) despite careful management on multiple daily injections (MDI).Aims: Our aims were to determine impact of CSII therapy on glycaemic control, BMI, incidence of severe hypoglycaemia and episodes of diabetic ketoac...